+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biosurgery Market by Product Type, Material Type, Application, End User, Resorbability - Global Forecast to 2030- Product Image
Biosurgery Market by Product Type, Material Type, Application, End User, Resorbability - Global Forecast to 2030- Product Image
Sale

Biosurgery Market by Product Type, Material Type, Application, End User, Resorbability - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082626
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biosurgery market is evolving rapidly, propelled by advanced biomaterial innovations, shifts in surgical protocols, and increased demand for precision in surgical outcomes. This transformation is driving new opportunities for senior decision-makers aiming to align their strategies with changing industry dynamics.

Market Snapshot: Biosurgery Market Growth and Forecast

According to recent research, the biosurgery market grew from USD 16.35 billion in 2024 to USD 17.70 billion in 2025. It is projected to maintain strong momentum at a compound annual growth rate (CAGR) of 8.20%, with forecasts placing market value at USD 26.25 billion by 2030. This upward trajectory reflects increasing adoption of advanced biosurgical solutions across global healthcare systems, with rising clinical demands and ongoing product innovation driving growth. Clear articulation of market size and projections underscores the biosurgery market’s expanding relevance for strategic investments.

Scope & Segmentation of the Biosurgery Market

This comprehensive research report analyzes the biosurgery market across multiple critical dimensions, providing actionable intelligence for decision-makers. Key segmentation areas include:

  • Product Types: Hemostats, sealants and adhesives, tissue regeneration solutions.
  • Hemostat Subtypes: Fibrin-based hemostats, gelatin-based hemostats.
  • Sealant & Adhesive Subtypes: Cyanoacrylate adhesives, fibrin sealants, synthetic sealants.
  • Tissue Regeneration Subtypes: Allograft regeneration, collagen-based regeneration, synthetic regeneration, xenograft regeneration.
  • Material Types: Collagen-based, fibrin-based, gelatin-based, synthetic.
  • Applications: Cardiovascular surgery, general surgery, minimally invasive surgery, open surgery, orthopedic surgery.
  • Orthopedic Surgery Applications: Joint replacement, spinal fusion.
  • End Users: Ambulatory surgery centers, hospitals, specialty clinics (including dental and ophthalmology clinics).
  • Resorbability Profiles: Nonresorbable, fully resorbable, partially resorbable.
  • Regional Coverage: Americas, Europe-Middle East-Africa, Asia-Pacific, with additional granularity for major markets such as the United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina, and prominent countries within Europe, Middle East, Africa, and Asia-Pacific.
  • Key Companies: Johnson & Johnson, Medtronic plc, Baxter International Inc., Stryker Corporation, B. Braun Melsungen AG, Becton, Dickinson and Company, Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, CryoLife, Inc., Terumo Corporation.

Biosurgery Market: Key Takeaways

  • Advanced biomaterials and manufacturing methods are accelerating innovation, resulting in more effective hemostatic and tissue regeneration products.
  • Expanding application areas, including minimally invasive and orthopedic surgeries, are broadening the addressable market and increasing demand for specialized solutions.
  • Regulatory changes are compelling manufacturers to adopt higher transparency and rigorous compliance practices throughout the value chain.
  • Regional demand patterns reflect varying healthcare infrastructure maturity, with collaboration between global suppliers and local manufacturers facilitating technology transfer and adoption.
  • Competitive differentiation depends on intellectual property, robust R&D, regulatory agility, and go-to-market flexibility.
  • End user diversity, from ambulatory surgery centers to specialty clinics, is driving product customization to meet unique operational requirements.

Tariff Impact on the Biosurgery Industry

The anticipated update to US tariff schedules in 2025 is expected to influence the biosurgery supply chain by increasing input costs for globally sourced materials and device components. Companies are responding with near-shoring, investments in local production, and negotiation with regulatory bodies to reduce tariff exposure. This environment favors organizations able to rapidly adapt procurement strategies, secure supply chains, and maintain product innovation and differentiation.

Methodology & Data Sources

The findings are based on primary interviews with senior executives, procurement leaders, and clinical experts, supported by secondary sources such as peer-reviewed journals, regulatory documents, corporate reports, and established industry databases. Quantitative insights come from triangulated financial data and procurement records, while qualitative trends are validated through thematic analysis and expert workshops.

Why This Report Matters

  • Strategic insights guide investment, product, and expansion decisions in a fast-evolving biosurgery landscape.
  • Detailed segmentation and region-specific intelligence help optimize go-to-market strategies for diverse healthcare environments.
  • Key recommendations provide a roadmap for navigating regulatory shifts, enhancing supply chain resilience, and sustaining competitive differentiation.

Conclusion

Senior leaders will find this analysis valuable for tracking biosurgery trends, evaluating risks, and identifying growth opportunities. Robust segmentation, actionable insights, and transparent methodology make this report a critical resource for informed strategic planning.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biosurgery Market, by Product Type
8.1. Introduction
8.2. Hemostats
8.2.1. Fibrin-Based Hemostats
8.2.2. Gelatin-Based Hemostats
8.3. Sealants And Adhesives
8.3.1. Cyanoacrylate Adhesives
8.3.2. Fibrin Sealants
8.3.3. Synthetic Sealants
8.4. Tissue Regeneration
8.4.1. Allograft Regeneration
8.4.2. Collagen-Based Regeneration
8.4.3. Synthetic Regeneration
8.4.4. Xenograft Regeneration
9. Biosurgery Market, by Material Type
9.1. Introduction
9.2. Collagen-Based
9.3. Fibrin-Based
9.4. Gelatin-Based
9.5. Synthetic
10. Biosurgery Market, by Application
10.1. Introduction
10.2. Cardiovascular Surgery
10.2.1. Bypass Surgery
10.2.2. Valve Repair
10.3. General Surgery
10.3.1. Hernia Repair
10.3.2. Wound Repair
10.4. Minimally Invasive Surgery
10.4.1. Endoscopic
10.4.2. Laparoscopic
10.5. Open Surgery
10.6. Orthopedic Surgery
10.6.1. Joint Replacement
10.6.2. Spinal Fusion
11. Biosurgery Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Hospitals
11.3.1. Inpatient Services
11.3.2. Outpatient Services
11.4. Specialty Clinics
11.4.1. Dental Clinics
11.4.2. Ophthalmology Clinics
12. Biosurgery Market, by Resorbability
12.1. Introduction
12.2. Nonresorbable
12.3. Resorbable
12.3.1. Fully Resorbable
12.3.2. Partially Resorbable
13. Americas Biosurgery Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Biosurgery Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Biosurgery Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. Medtronic plc
16.3.3. Baxter International Inc.
16.3.4. Stryker Corporation
16.3.5. B. Braun Melsungen AG
16.3.6. Becton, Dickinson and Company
16.3.7. Zimmer Biomet Holdings, Inc.
16.3.8. Integra LifeSciences Holdings Corporation
16.3.9. CryoLife, Inc.
16.3.10. Terumo Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOSURGERY MARKET MULTI-CURRENCY
FIGURE 2. BIOSURGERY MARKET MULTI-LANGUAGE
FIGURE 3. BIOSURGERY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOSURGERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOSURGERY MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOSURGERY MARKET SIZE, BY FIBRIN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOSURGERY MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOSURGERY MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOSURGERY MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOSURGERY MARKET SIZE, BY ALLOGRAFT REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOSURGERY MARKET SIZE, BY COLLAGEN-BASED REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOSURGERY MARKET SIZE, BY XENOGRAFT REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOSURGERY MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOSURGERY MARKET SIZE, BY FIBRIN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOSURGERY MARKET SIZE, BY GELATIN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOSURGERY MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOSURGERY MARKET SIZE, BY VALVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOSURGERY MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOSURGERY MARKET SIZE, BY WOUND REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOSURGERY MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOSURGERY MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOSURGERY MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOSURGERY MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOSURGERY MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOSURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOSURGERY MARKET SIZE, BY INPATIENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOSURGERY MARKET SIZE, BY OUTPATIENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOSURGERY MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOSURGERY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOSURGERY MARKET SIZE, BY NONRESORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOSURGERY MARKET SIZE, BY FULLY RESORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOSURGERY MARKET SIZE, BY PARTIALLY RESORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 93. CANADA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 95. CANADA BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 96. CANADA BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 97. CANADA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 98. CANADA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 100. CANADA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 101. CANADA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 102. CANADA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 103. CANADA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. CANADA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 105. CANADA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 106. CANADA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 107. CANADA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 111. MEXICO BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 122. MEXICO BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 184. GERMANY BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 186. GERMANY BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 187. GERMANY BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 188. GERMANY BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 189. GERMANY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. GERMANY BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 191. GERMANY BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 192. GERMANY BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 193. GERMANY BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 194. GERMANY BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. GERMANY BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 196. GERMANY BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 197. GERMANY BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 198. GERMANY BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 199. FRANCE BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 201. FRANCE BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 202. FRANCE BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 203. FRANCE BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 204. FRANCE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. FRANCE BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 206. FRANCE BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 207. FRANCE BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 208. FRANCE BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 209. FRANCE BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. FRANCE BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. FRANCE BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 212. FRANCE BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 213. FRANCE BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 229. ITALY BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. ITALY BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 231. ITALY BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 232. ITALY BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 233. ITALY BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 234. ITALY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. ITALY BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 236. ITALY BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 237. ITALY BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 238. ITALY BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 239. ITALY BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. ITALY BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. ITALY BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 242. ITALY BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 243. ITALY BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 244. SPAIN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. SPAIN BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 246. SPAIN BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 247. SPAIN BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 248. SPAIN BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SPAIN BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 251. SPAIN BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 252. SPAIN BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 253. SPAIN BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 254. SPAIN BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. SPAIN BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 256. SPAIN BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 257. SPAIN BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 258. SPAIN BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 304. DENMARK BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. DENMARK BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 306. DENMARK BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 307. DENMARK BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 308. DENMARK BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 309. DENMARK BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. DENMARK BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 311. DENMARK BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 312. DENMARK BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 313. DENMARK BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 314. DENMARK BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. DENMARK BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 316. DENMARK BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 317. DENMARK BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 318. DENMARK BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 327. NETHERLANDS BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 328. NETHERLANDS BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 329. NETHERLANDS BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. NETHERLANDS BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 331. NETHERLANDS BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 332. NETHERLANDS BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 333. NETHERLANDS BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 334. QATAR BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 335. QATAR BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 336. QATAR BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 337. QATAR BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 338. QATAR BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 339. QATAR BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 340. QATAR BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 341. QATAR BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 342. QATAR BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 343. QATAR BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 344. QATAR BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 345. QATAR BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 346. QATAR BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 347. QATAR BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 348. QATAR BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 349. FINLAND BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 350. FINLAND BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 351. FINLAND BIOSURGERY MARKET SIZE, BY SEALANTS AND ADHESIVES, 2018-2030 (USD MILLION)
TABLE 352. FINLAND BIOSURGERY MARKET SIZE, BY TISSUE REGENERATION, 2018-2030 (USD MILLION)
TABLE 353. FINLAND BIOSURGERY MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 354. FINLAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 355. FINLAND BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 356. FINLAND BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 357. FINLAND BIOSURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 358. FINLAND BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 359. FINLAND BIOSURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 360. FINLAND BIOSURGERY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 361. FINLAND BIOSURGERY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 362. FINLAND BIOSURGERY MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 363. FINLAND BIOSURGERY MARKET SIZE, BY RESORBABLE, 2018-2030 (USD MILLION)
TABLE 364. SWEDEN BIOSURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 365. SWEDEN BIOSURGERY MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biosurgery market report include:
  • Johnson & Johnson
  • Medtronic plc
  • Baxter International Inc.
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Zimmer Biomet Holdings, Inc.
  • Integra LifeSciences Holdings Corporation
  • CryoLife, Inc.
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 17.7 Billion
Forecasted Market Value ( USD ) by 2030 $ 26.25 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biosurgery - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Biosurgery - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Biosurgery Market Size, Share and Trends Analysis Report by Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), Application (General Surgery, Orthopedic Surgery), and Region 2024-2030 - Product Image

Biosurgery Market Size, Share and Trends Analysis Report by Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), Application (General Surgery, Orthopedic Surgery), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Biosurgery Market Report by Product, Source, Application, End User, and Region 2024-2032 - Product Image

Biosurgery Market Report by Product, Source, Application, End User, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Biosurgery Market Report 2025 - Product Image

Biosurgery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Biosurgery Market based by Product Type, By Application, By Source, Regional Outlook - Global Forecast up to 2030 - Product Image

Biosurgery Market based by Product Type, By Application, By Source, Regional Outlook - Global Forecast up to 2030

  • Report
  • 146 Pages
  • Global
From

About the Biosurgery Market

Biosurgery is a rapidly growing field of medical technology that focuses on the use of biological materials to repair, replace, or supplement damaged or missing tissue. It is used in a variety of surgical procedures, including reconstructive surgery, orthopedic surgery, and plastic surgery. Biosurgery products are designed to provide a more natural and effective solution to tissue repair and regeneration. These products are often made from biocompatible materials, such as collagen, hyaluronic acid, and other proteins, and are designed to be minimally invasive and to reduce the risk of infection. Biosurgery products are used in a variety of surgical procedures, including wound healing, tissue engineering, and regenerative medicine. They are also used to treat a variety of conditions, such as burns, ulcers, and hernias. Biosurgery products are also used in cosmetic surgery, such as breast augmentation and facial reconstruction. Some of the companies in the biosurgery market include Allergan, Baxter, Bausch Health, Covidien, Johnson & Johnson, Medtronic, and Smith & Nephew. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.